Latest News about CLSD
Recent news which mentions CLSD
Earnings Scheduled For November 12, 2024
November 12, 2024
From Benzinga
Clearside Biomedical's Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study
October 09, 2024
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 09, 2024
From Benzinga
Tickers
CLSD
From InvestorPlace
Why Is Clearside Biomedical Stock Gaining Today?
June 25, 2024
From Benzinga
From Benzinga
From Benzinga
Tickers
CLSD
From InvestorPlace
From Benzinga
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
April 22, 2024
From Benzinga
7 Top Stocks Under $7
April 11, 2024
From InvestorPlace
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
From Benzinga
Earnings Scheduled For March 12, 2024
March 12, 2024
From Benzinga
From Benzinga
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
February 25, 2024
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
From Benzinga
Top 5 Health Care Stocks That May Crash This Month
January 22, 2024
From Benzinga
Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness
January 17, 2024
From Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
From Benzinga
Over $2M Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
November 02, 2023
From Benzinga
3 Cheap Stocks to Buy Under $1 in October 2023
October 26, 2023
From InvestorPlace
Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying
October 05, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.